124 related articles for article (PubMed ID: 38704029)
1. Opening the black box: spatial transcriptomics and the relevance of AI-detected prognostic regions in high grade serous carcinoma.
Laury AR; Zheng S; Aho N; Fallegger R; Hänninen S; Saez-Rodriguez J; Tanevski J; Youssef O; Tang J; Carpén OM
Mod Pathol; 2024 May; ():100508. PubMed ID: 38704029
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence-based image analysis can predict outcome in high-grade serous carcinoma via histology alone.
Laury AR; Blom S; Ropponen T; Virtanen A; Carpén OM
Sci Rep; 2021 Sep; 11(1):19165. PubMed ID: 34580357
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract][Full Text] [Related]
4. Single-cell RNA-sequencing analysis reveals divergent transcriptome events between platinum-sensitive and platinum-resistant high-grade serous ovarian carcinoma.
Wang Z; Yang L; Su X; Wu X; Su R
J Gene Med; 2023 Oct; 25(10):e3504. PubMed ID: 36994597
[TBL] [Abstract][Full Text] [Related]
5. Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors.
Ferri-Borgogno S; Zhu Y; Sheng J; Burks JK; Gomez JA; Wong KK; Wong STC; Mok SC
Cancer Res; 2023 May; 83(9):1503-1516. PubMed ID: 36787106
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinoma.
Tessier-Cloutier B; Cochrane DR; Karnezis AN; Colborne S; Magrill J; Talhouk A; Zhang J; Leung S; Hughes CS; Piskorz A; Cheng AS; Greening K; du Bois A; Pfisterer J; Soslow RA; Kommoss S; Brenton JD; Morin GB; Gilks CB; Huntsman DG; Kommoss F
Hum Pathol; 2020 Jul; 101():40-52. PubMed ID: 32360491
[TBL] [Abstract][Full Text] [Related]
8. A deep learning algorithm to detect cutaneous squamous cell carcinoma on frozen sections in Mohs micrographic surgery: a retrospective assessment.
Davis MJ; Srinivasan G; Chacko R; Chen S; Suvarna A; Vaickus LJ; Torres VC; Hodge S; Chen EY; Preum S; Samkoe KS; Christensen BC; LeBoeuf M; Levy JJ
medRxiv; 2023 May; ():. PubMed ID: 37293008
[TBL] [Abstract][Full Text] [Related]
9. A Fully Automated Artificial Intelligence System to Assist Pathologists' Diagnosis to Predict Histologically High-grade Urothelial Carcinoma from Digitized Urine Cytology Slides Using Deep Learning.
Tsuji K; Kaneko M; Harada Y; Fujihara A; Ueno K; Nakanishi M; Konishi E; Takamatsu T; Horiguchi G; Teramukai S; Ito-Ihara T; Ukimura O
Eur Urol Oncol; 2024 Apr; 7(2):258-265. PubMed ID: 38065702
[TBL] [Abstract][Full Text] [Related]
10. External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma.
Lee JY; Chung YS; Na K; Kim HM; Park CK; Nam EJ; Kim S; Kim SW; Kim YT; Kim HS
J Gynecol Oncol; 2017 Nov; 28(6):e73. PubMed ID: 28758379
[TBL] [Abstract][Full Text] [Related]
11. Network vulnerability-based and knowledge-guided identification of microRNA biomarkers indicating platinum resistance in high-grade serous ovarian cancer.
Qi X; Yu C; Wang Y; Lin Y; Shen B
Clin Transl Med; 2019 Oct; 8(1):28. PubMed ID: 31664600
[TBL] [Abstract][Full Text] [Related]
12. Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma.
Chui MH; Momeni Boroujeni A; Mandelker D; Ladanyi M; Soslow RA
Mod Pathol; 2021 Feb; 34(2):490-501. PubMed ID: 32801341
[TBL] [Abstract][Full Text] [Related]
13. ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors.
Kaipio K; Chen P; Roering P; Huhtinen K; Mikkonen P; Östling P; Lehtinen L; Mansuri N; Korpela T; Potdar S; Hynninen J; Auranen A; Grénman S; Wennerberg K; Hautaniemi S; Carpén O
J Pathol; 2020 Feb; 250(2):159-169. PubMed ID: 31595974
[TBL] [Abstract][Full Text] [Related]
14. Immunotyping in tubo-ovarian high-grade serous carcinoma by PD-L1 and CD8+ T-lymphocytes predicts disease-free survival.
Bansal A; Srinivasan R; Rohilla M; Rai B; Rajwanshi A; Suri V; Chandra Saha S
APMIS; 2021 May; 129(5):254-264. PubMed ID: 33455015
[TBL] [Abstract][Full Text] [Related]
15. Defining the molecular evolution of extrauterine high grade serous carcinoma.
Beirne JP; McArt DG; Roddy A; McDermott C; Ferris J; Buckley NE; Coulter P; McCabe N; Eddie SL; Dunne PD; O'Reilly P; Gilmore A; Feeney L; Ewing DL; Drapkin RI; Salto-Tellez M; Kennedy RD; Harley IJG; McCluggage WG; Mullan PB
Gynecol Oncol; 2019 Nov; 155(2):305-317. PubMed ID: 31493898
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of GRIM-19, NF-κB and IKK2 in patients with high-grade serous ovarian cancer.
Ilelis F; do Amaral NS; Alves MR; da Costa AABA; Calsavara VF; Lordello L; De Brot L; Soares FA; Rodrigues IS; Rocha RM
Pathol Res Pract; 2018 Feb; 214(2):187-194. PubMed ID: 29254797
[TBL] [Abstract][Full Text] [Related]
17. Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma.
Marchocki Z; Tone A; Virtanen C; de Borja R; Clarke B; Brown T; May T
J Ovarian Res; 2022 May; 15(1):50. PubMed ID: 35501919
[TBL] [Abstract][Full Text] [Related]
18. Highly Expressed Progesterone Receptor B Isoform Increases Platinum Sensitivity and Survival of Ovarian High-Grade Serous Carcinoma.
Lin H; Lan KC; Ou YC; Wu CH; Kang HY; Chuang IC; Fu HC
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771742
[TBL] [Abstract][Full Text] [Related]
19. Morphological Features Extracted by AI Associated with Spatial Transcriptomics in Prostate Cancer.
Chelebian E; Avenel C; Kartasalo K; Marklund M; Tanoglidi A; Mirtti T; Colling R; Erickson A; Lamb AD; Lundeberg J; Wählby C
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638322
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC).
Ditzel HM; Strickland KC; Meserve EE; Stover E; Konstantinopoulos PA; Matulonis UA; Muto MG; Liu JF; Feltmate C; Horowitz N; Berkowitz RS; Gupta M; Hecht JL; Lin DI; Jochumsen KM; Welch WR; Hirsch MS; Quade BJ; Lee KR; Crum CP; Mutter GL; Nucci MR; Howitt BE
Int J Gynecol Pathol; 2019 May; 38(3):230-240. PubMed ID: 29750700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
